Top
US_Flag An official website of the United States government Here's how you know
GOV

The .gov means it's official.

Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

LOCK

The site is secure.

The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

 
U.S. Food & Drug Administration
Continuing Education and Accreditation
Division of Learning and Organizational Development
Center for Drug Evaluation and Research

Understanding Generic Narrow Therapeutic Index Drugs

Enroll
Step Status
Educational Content ✘
Posttest ✘
Evaluation ✘
Starts On: Tue, 1/10/23: 12:00 AM EST
Ends On: Sat, 11/1/25: 12:00 AM EDT
Type: Enduring Material
Credits: 1
Description: This webinar will provide health care providers with information and knowledge on how to answer questions that patients may have about narrow therapeutic index (NTI) generic drugs, such as how the FDA recognizes the importance of bioequivalence in NTI generic drugs and has stricter standards for bioequivalence of NTI drugs than for other generic drugs. The presentation will also give providers information on FDA's post-market research efforts to ensure therapeutic equivalence of generic NTI drugs.
Objectives:
  • Explain how to utilize FDA's Drug Information, medication safety resources, and regulatory guidances to improve delivery of patient care and optimize outcomes.

  • Describe and inform health care providers of recent labeling, policy and regulatory changes which would impact prescribing and medication management to optimize patient care.
Additional Information: Review the Activity Announcement for additional details: Announcement Form

Additional Resources: SLIDES